Two Sigma Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-16,100
Closed -$1.86M 3480
2023
Q3
$1.86M Sell
16,100
-89,300
-85% -$9.59M 0.01% 1445
2023
Q2
$10.8M Buy
105,400
+73,100
+226% +$7.71M 0.03% 606
2023
Q1
$3.53M Buy
32,300
+18,400
+132% +$2.03M 0.01% 1069
2022
Q4
$1.58M Sell
13,900
-326,500
-96% -$27.1M 0.01% 1444
2022
Q3
$21.1M Buy
+340,400
New +$23.8M 0.07% 313
2022
Q1
Sell
-4,386
Closed -$473K 4812
2021
Q4
$473K Buy
+4,386
New +$478K ﹤0.01% 3305
2021
Q2
Sell
-2,905
Closed -$267K 4817
2021
Q1
$267K Sell
2,905
-20,387
-88% -$1.72M ﹤0.01% 3420
2020
Q4
$1.7M Sell
23,292
-423,991
-95% -$31.5M ﹤0.01% 1598
2020
Q3
$34.7M Buy
447,283
+371,596
+491% +$25.6M 0.12% 168
2020
Q2
$4.21M Buy
+75,687
New +$3.24M 0.02% 720
2020
Q1
Sell
-266,624
Closed -$9.65M 4147
2019
Q4
$9.65M Sell
266,624
-149,989
-36% -$4.6M 0.03% 637
2019
Q3
$11.3M Sell
416,613
-418,050
-50% -$10.8M 0.04% 509
2019
Q2
$20.1M Sell
834,663
-303,090
-27% -$7.69M 0.07% 352
2019
Q1
$30.1M Sell
1,137,753
-625,835
-35% -$14.8M 0.1% 269
2018
Q4
$34.5M Buy
1,763,588
+805,770
+84% +$15.8M 0.13% 200
2018
Q3
$18.8M Buy
957,818
+192,267
+25% +$3.66M 0.05% 435
2018
Q2
$12.7M Buy
765,551
+405,958
+113% +$6.19M 0.04% 567
2018
Q1
$5.11M Sell
359,593
-150,195
-29% -$2.22M 0.02% 939
2017
Q4
$7.44M Buy
+509,788
New +$7.16M 0.02% 717
2017
Q2
Sell
-58,397
Closed -$863K 3447
2017
Q1
$863K Buy
58,397
+39,246
+205% +$636K ﹤0.01% 2013
2016
Q4
$310K Buy
+19,151
New +$347K ﹤0.01% 2739
2016
Q1
Sell
-186,349
Closed -$3.26M 3273
2015
Q4
$4.04M Buy
+186,349
New +$3.63M 0.02% 750
2015
Q3
Sell
-110,755
Closed -$3.85M 2979
2015
Q2
$3.85M Sell
110,755
-167,575
-60% -$5.11M 0.02% 843
2015
Q1
$7.23M Buy
+278,330
New +$5.1M 0.03% 576
2014
Q2
Sell
-78,510
Closed -$1.19M 2449
2014
Q1
$1.19M Sell
78,510
-91,687
-54% -$1.04M 0.01% 1141
2013
Q4
$1.3M Buy
170,197
+159,497
+1,491% +$860K 0.01% 1207
2013
Q3
$36K Buy
+10,700
New +$28.2K ﹤0.01% 1790

Other funds holding HZNP

Two Sigma Investments's HZNP Position: Q4 2023 in Review

Two Sigma Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 16,100 shares — an estimated $1.86M sold.

Two Sigma Investments first reported a position in HZNP in Q3 2013 and held it in 27 quarters. The position peaked at $34.7M in Q3 2020. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Two Sigma Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Investments sold 16,100 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.86M.
  • Two Sigma Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2013 and held it in 27 quarters.
  • Two Sigma Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $34.7M in Q3 2020.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.